(1 - 21 from 39
)
Beau Wrigley Jr.'s Parallel to go public - Atlanta Business Chroniclewww.bizjournals.com › atlanta › news › › beau-wrigley-parall...
www.bizjournals.com
Feb 22, · Marina Bozilenko, strategic advisor to William Blair and Company. Dr. Kevin Douglas, medical director of U.S. Rheumatology and study ...
Eastbourne proposes Amylin directors, backs Icahn - Bloombergwww.reuters.com › article › eastbourne-proposes-amylin-directors-backs-ic...
www.reuters.com
Feb 2, · ... selected Kathleen Behrens, Marina Bozilenko, Charles Fleischman, William Nuerge, and Jay Sherwood for the board, the agency said.
Fireside chat: What is really driving the value for Biopharma? - faccnefaccne.org › event › fireside-chat-what-is-really-driving-the-value-for-biop...
faccne.org
Nov 26, · The discussion will be driven by Marina Bozilenko Head of Biotech & Pharma, Managing Director, at William Blair & Company.
U.S. Cannabis Player Parallel To Go Public, Valued At $1.9 Billionwww.shankennewsdaily.com › index.php › › u-s-cannabis-pla...
www.shankennewsdaily.com
Feb 23, · ... directors will include Crouthers and Parallel's general counsel Phil Harris, along with Marina Bozilenko, Kevin Douglas, Sarah Hassan, ...
sorted by relevance / date